NCT04030455 2026-03-09
Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
Clinical Trials
36 trialsNCT02589938 2026-02-27
ACUPUNCTURE
Wake Forest University Health Sciences
Phase NA Completed
NCT03174275 2026-02-23
Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma
UNC Lineberger Comprehensive Cancer Center
Phase 2 Active not recruiting
NCT03258554 2026-02-06
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
National Cancer Institute (NCI)
Phase 2/3 Completed
NCT06129487 2025-11-14
Evaluations of Alcohol Warning Labels
University of Connecticut
Phase NA Completed
NCT02586207 2025-10-07
Pembrolizumab in Combination With CRT for LA-SCCHN
Sanford Health
Phase 1 Completed
NCT00593840 2025-05-11
Phase II Trial Evaluating Elimination of Radiation Therapy
Washington University School of Medicine
Phase 2 Active not recruiting
NCT04162873 2025-02-12
Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer
University of Utah
Phase 2 Terminated
NCT02113878 2024-11-05
Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck
Dana-Farber Cancer Institute
Phase 1 Completed
NCT04541355 2024-06-28
Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin
University of California, San Francisco
Phase 2 Completed
NCT00743262 2023-07-25
Short-term Clinical Feasibility of the New Provox Vega 22.5 Voice Prosthesis
Atos Medical AB
Phase 1/2 Completed
NCT01633541 2023-07-20
Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT03254927 2023-04-03
A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma
Celldex Therapeutics
Phase 2 Terminated
NCT01045057 2021-06-11
Clinical Feasibility of New Tracheoesophageal Puncture Set
Atos Medical AB
Phase NA Completed
NCT04458818 2021-04-29
A Novel Approach for Thyroplasty Type 1, With Prolene Mesh. A Prospective Study.
Pak Emirates Military Hospital
Phase NA Completed
NCT02633540 2021-03-09
Investigation of Contralateral Arytenoid Sparing IMRT for T1a & T2a Larynx Cancer & Analysis of Post-treatment Laryngeal Function
Fox Chase Cancer Center
Phase 2 Terminated
NCT00833261 2020-08-21
Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer
University of Texas Southwestern Medical Center
Phase 2 Completed
NCT00524017 2020-03-12
Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00656513 2019-11-19
Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer
Radiation Therapy Oncology Group
Phase 2/3 Completed
NCT01806675 2019-10-03
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
Stanford University
Phase 1/2 Completed
NCT02062632 2019-10-01
Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy
Mayo Clinic
Phase 2 Terminated
NCT01194466 2019-09-17
Transcutaneous Electrical Nerve Stimulation (TENS) and Head and Neck Cancer Pain (HNC) (TENS & HNC)
University of Iowa
Phase NA Completed
NCT00721799 2019-08-06
F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients
University of Iowa
Phase 2 Completed
NCT00790569 2018-06-06
Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking
Butler Hospital
Phase NA Completed
NCT00117572 2018-04-09
DeCIDE
University of Chicago
Phase 3 Completed
NCT00462735 2018-03-13
Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer
Icahn School of Medicine at Mount Sinai
Phase 2 Completed
NCT00797732 2018-02-13
A Pilot Study of Acupuncture Treatment for Dysphagia
Dana-Farber Cancer Institute
Phase NA Completed
NCT00666978 2017-11-13
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
University of Kansas Medical Center
Phase 4 Completed
NCT00534001 2017-05-30
Bupropion in Helping Adults Stop Smoking
Roswell Park Cancer Institute
Phase 2 Completed
NCT00970502 2017-04-10
Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer
Icahn School of Medicine at Mount Sinai
Phase 1/2 Completed
NCT00661570 2017-03-10
Long-term Clinical Feasibility of the New Indwelling Provox Vega 20 Voice Prosthesis
Atos Medical AB
Phase NA Terminated
NCT00957424 2017-02-07
Acceptability of Less Harmful Alternatives to Cigarettes
Roswell Park Cancer Institute
Phase NA Completed
NCT00721539 2016-11-03
Assessing the da Vinci® Robotic Surgical System for Surgery of the Upper Aerodigestive Tract
Stanford University
Phase NA Terminated
NCT00365508 2016-03-29
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Fox Chase Cancer Center
Phase 4 Completed
NCT00599131 2015-12-03
Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE)
University of Michigan Rogel Cancer Center
Phase 2 Terminated
NCT00530088 2014-07-04
Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Recurrent Mouth or Throat Dysplasia or Recurrent In Situ Cancer or Stage I Cancer of the Mouth or Throat
Roswell Park Cancer Institute
Phase NA Terminated